BIOTALYS NV (BTLS.BR) Stock Cash Flow
Europe - EBR:BTLS - BE0974386188 - Common Stock
4.32 EUR
+0.02 (+0.47%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.49M | -20.89M | -22.53M | -18.08M | -13.28M | |||
| Depreciation Amortization | 1.83M | 1.79M | 1.57M | 1.47M | 1.04M | |||
| Change In Working Capital | -1.07M | 265.00K | -45.00K | -640.00K | 2.12M | |||
| Interest Paid | 156.00K | 159.00K | 245.00K | 240.00K | 40.00K | |||
| Taxes Paid | N/A | 154.00K | 24.00K | 410.00K | 440.00K | |||
| Other non cash items | 83.00K | 557.00K | 910.00K | 500.00K | 580.00K | |||
| OPERATING CASH FLOW | -12.65M | -18.28M | -20.09M | -16.75M | -9.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -138.00K | -455.00K | -707.00K | -1.33M | -3.93M | |||
| Other Investing Activity | 715.00K | 688.00K | 23.00K | 10.00K | -2.09M | |||
| INVESTING CASH FLOW | 577.00K | 233.00K | -684.00K | -1.32M | -6.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.25M | -1.27M | -1.23M | 1.65M | 200.00K | |||
| Stock Issued/Repurchased | 14.55M | 6.96M | 236.00K | 49.68M | 15.14M | |||
| Other Financing Activity | -156.00K | -158.00K | -245.00K | -250.00K | -40.00K | |||
| FINANCING CASH FLOW | 13.14M | 5.53M | -1.24M | 51.08M | 15.30M | |||
| Exchange Rate Effect | 0.00 | -5.00K | 6.00K | N/A | N/A | |||
| CHANGE IN CASH | 1.07M | -12.53M | -22.01M | 33.01M | -250.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.65M | -18.28M | -20.09M | -16.75M | -9.53M | |||
| Capital Expenditure | -138.00K | -455.00K | -707.00K | -1.33M | -3.93M | |||
| FREE CASH FLOW | -12.79M | -18.74M | -20.80M | -18.08M | -13.46M | |||
All data in EUR